• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
H.C. Wainwright Reiterates Buy Rating on Bolt Biotherapeutics
16:02
Nov13
Bolt Biotherapeutics released FY2025 9 Months Earnings on November 12, 2025 EST, with actual revenue of USD 5.195 M and EPS of USD -13.9453
04:00
Bolt Biotherapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 2.169 M (forecast USD 820.8 K), actual EPS USD -3.7219 (forecast USD -5.426)
04:00
Aug15
Bolt Biotherapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.804 M (forecast USD 819.75 K), actual EPS USD -4.4643 (forecast USD -6.45)
03:00
Bolt Biotherapeutics released FY2025 Semi-Annual Earnings on August 14 EST, with actual revenue of USD 3.026 M and EPS of USD -10.2232
03:00
Jun11
Squarepoint Ops LLC Acquires New Shares of Bolt Biotherapeutics
07:29

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.169 M, Net Income -7.144 M, EPS -3.7219

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.804 M, Net Income -8.561 M, EPS -4.4643

Jun9
Reverse Stock Split(EST)

1-for-20 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More